Drugs / NKAEs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01944982 | Jul 2013 → Sep 2016 | childhood precursor T-lymphoblastic lymphoma/leukemia | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NKAEs | “Expanded haploidentical natural killer cells (NKAEs)” NCT01944982 ↗ |
| Known as | NKAE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01944982 ↗ |
| Modality | Cell therapy | “infusion of fresh NKAE cell therapy is feasible and safe” PMID 29477379 ↗ Feb 2018 |